📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Valiant Organics Q3 FY26 Net Profit Rises 30.5% YoY to ₹6.06 Cr; Exceptional Gain of ₹5.72 Cr
Valiant Organics reported a standalone net profit of ₹6.06 crore for the quarter ended December 31, 2025, marking a 30.5% increase from ₹4.65 crore in the previous year's corresponding quarter. While revenue from operations declined 14.8% year-on-year to ₹159.07 crore, the company showed sequential stability. Profitability was significantly aided by an exceptional gain of ₹5.72 crore from a fire insurance claim settlement. Notably, the company has achieved a turnaround for the nine-month period, posting a profit of ₹19.24 crore compared to a loss of ₹6.95 crore in the prior year period.
Key Highlights
Standalone Net Profit increased to ₹6.06 crore in Q3 FY26 from ₹4.65 crore in Q3 FY25.
Revenue from operations stood at ₹159.07 crore, a slight sequential increase from ₹157.21 crore in Q2 FY26.
Recognized an exceptional gain of ₹5.72 crore relating to a fire insurance claim settlement for the Sarigam Division.
Finance costs decreased significantly to ₹4.56 crore compared to ₹5.83 crore in the same quarter last year.
9-month FY26 standalone profit reached ₹19.24 crore, reversing a net loss of ₹6.95 crore in 9M FY25.
💼 Action for Investors
Investors should note the company's successful turnaround into profitability and the reduction in finance costs, which indicates better debt management. Monitor the execution of the new manufacturing agreement with Aarti Pharmalabs for potential long-term revenue growth.
Valiant Organics Q3 Standalone Net Profit Rises 30.5% YoY to ₹6.06 Cr; Revenue Dips 14.8%
Valiant Organics reported a standalone net profit of ₹6.06 crore for Q3 FY26, a 30.5% increase from ₹4.65 crore in the same quarter last year, despite a 14.8% decline in revenue to ₹159.07 crore. The bottom line was significantly bolstered by an exceptional gain of ₹5.72 crore from a fire insurance claim settlement related to a past fire incident. For the nine-month period ended December 2025, the company achieved a major turnaround with a profit of ₹19.24 crore compared to a loss of ₹6.95 crore in the previous year. Finance costs also saw a healthy reduction, dropping to ₹4.56 crore from ₹5.83 crore YoY.
Key Highlights
Standalone Net Profit grew 30.5% YoY to ₹6.06 crore, aided by a ₹5.72 crore exceptional insurance gain.
Revenue from operations fell 14.8% YoY to ₹159.07 crore, though it showed a marginal 1.2% growth on a QoQ basis.
9M FY26 performance shows a sharp recovery with a net profit of ₹19.24 crore versus a loss of ₹6.95 crore in 9M FY25.
Finance costs for the quarter reduced by 21.8% YoY to ₹4.56 crore, reflecting improved debt management.
Basic EPS improved significantly to ₹2.16 in Q3 FY26 from ₹1.18 in the corresponding quarter of the previous year.
💼 Action for Investors
The company has successfully turned around from last year's losses, though the YoY revenue decline suggests ongoing pricing or volume pressure in the chemicals sector. Investors should monitor if core operational profitability can be sustained in the absence of one-time insurance gains.